Author

Salvatore Alesci

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Anita Ganjoo· 1 shared Heather FrancisiD· 1 shared Krishnan Nandabalan· 1 shared Lixian CheniD· 1 shared Meenakshi Chawla· 1 shared Sameer SharmaiD· 1 shared Shunichiro Okada· 1 shared Tianhao ZhouiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Anita Ganjoo

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

INVA8001, a Novel and Highly Selective Chymase Inhibitor, Ameliorates Liver Inflammation, Fibrosis, and Hyperplasia in Mdr2 Knockout Mice

Sameer Sharma, Lixian Chen, Tianhao Zhou, Meenakshi Chawla, Anita Ganjoo, Shunichiro Okada, Salvatore Alesci, Krishnan Nandabalan, Heather Francis

This study evaluates the efficacy of INVA8001, a chymase inhibitor, in reducing liver inflammation, fibrosis, and hyperplasia in Mdr2 knockout mice with PSC-like features.

Frontiers in Medicine · Jun 9, 2026Peer-reviewedPathology